Some animal studies, particularly those by Sikiric and colleagues, report gastrointestinal benefit from oral BPC-157, which is plausible given its origin as a gastric peptide with possible luminal activity
Delivers nutrients directly to the bloodstream, bypassing the digestive tract for efficient uptake
Inositol: Helps convert food into energy
Similarly, a pilot study in 2015, a clinical trial (randomised) on 42 healthy human participants, receiving oral (tablet form) dosages of BPC 157 was carried out (Clinicaltrials.gov 2018): 0.25, 0.5, 1 and 2 g/kg
Healthier Skin : Promote a radiant complexion and reduce signs of aging
From healing ulcers and inflammatory disorders to accelerating bone and joint healing, BPC 157 Peptides offer comprehensive support for your overall well-being